|
Indian pharmaceutical companies play a crucial role in providing, supplying, and offering effective, affordable, and high-quality assured antiretroviral (ARV) medications to South Africa and other developing countries such as Nigeria, Ghana, Kenya, Zambia, Japan, and Cambodia. This significantly lowers costs and expands access to antiretroviral treatment in the fight against HIV and AIDS.
This important contribution has enabled the large-scale expansion of the human immunodeficiency virus (HIV) program, with Indian generics often supplying the majority of AIDS medications. In this blog, we introduce Sunrise Remedies' contributions to South Africa.
Overview - India and Africa's partnership for access to medicines
The India-Africa partnership for access to medicines involves the supply of affordable Antiretroviral products, primarily Indian-made, to Africa, fostering local manufacturing capacity, and improving regulatory cooperation through agreements and mutual recognition.
India's partnership with Africa for antiretroviral access is characterized by its role as the "pharmacy of the developing world," leveraging its strong generic industry to provide affordable and high-quality ARVs.
Sunrise Remedies has reduced treatment costs for African nations, making life-saving treatments accessible to a large portion of the population and significantly impacting the fight against HIV/AIDS. The partnership extends beyond product provision to include healthcare, capacity building, and telemedicine.
|